tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
Hong Kong Market
Advertisement

CSPC Pharmaceutical Group (1093) Income Statement

Compare
18 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q4 2024), CSPC Pharmaceutical Group's total revenue was ¥12.96B, a decrease of -14.15% from the same quarter last year. In Q4, CSPC Pharmaceutical Group's net income was ¥1.33B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 29.54B¥ 31.47B¥ 31.59B¥ 27.41B¥ 23.58B
Gross Profit
¥ 20.67B¥ 22.19B¥ 22.73B¥ 20.79B¥ 17.67B
Operating Expenses
¥ 15.22B¥ 15.19B¥ 15.80B¥ 14.64B¥ 12.53B
Depreciation and Amortization
¥ 1.36B¥ 1.11B¥ 1.07B¥ 849.47M¥ 763.04M
EBITDA
¥ 7.18B¥ 8.59B¥ 8.85B¥ 7.57B¥ 6.80B
Operating Income
¥ 5.45B¥ 7.01B¥ 6.93B¥ 6.14B¥ 5.14B
Other Income/Expenses
¥ 229.71M¥ 388.72M¥ 811.55M¥ 591.96M¥ 904.76M
Pretax Income
¥ 5.68B¥ 7.39B¥ 7.74B¥ 6.73B¥ 6.04B
Net Income
¥ 4.41B¥ 5.88B¥ 6.22B¥ 5.51B¥ 4.88B
Per Share Metrics
Basic EPS
¥ 0.38¥ 0.50¥ 0.52¥ 0.46¥ 0.41
Diluted EPS
¥ 0.38¥ 0.49¥ 0.52¥ 0.46¥ 0.41
Weighted Average Shares Outstanding
11.74B 11.87B 11.92B 11.95B 11.95B
Weighted Average Shares Outstanding (Diluted)
11.74B 11.87B 11.92B 11.95B 11.96B
Currency in CNY

CSPC Pharmaceutical Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis